ADMA
ADMA Biologics, Inc.
NASDAQ · USHealthcareBiotechnology
$8.75+0.46%
Price as of Jul 20, 2026
ADMA capital
ADMA Biologics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.52x
- Net debt / equity
- 0.17x
- Debt / assets
- 0.31x
- Debt / EBITDA
- 0.92x
- Net debt / EBITDA
- 0.30x
Liquidity & coverage
- Current ratio
- 6.95x
- Quick ratio
- 3.93x
- Cash ratio
- 1.88x
- Interest coverage
- 28.59x
- EBITDA / interest
- 30.62x
- Working capital
- $437.6M
Cash & dividend
- FCF / debt
- 0.53x
- Cash flow / debt
- 0.63x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.